TY - JOUR
T1 - Enantioselective sulfoxidations employing the thermostable cyclohexanone monooxygenase from Thermocrispum municipale
AU - de Gonzalo, Gonzalo
AU - Franconetti, Antonio
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/6
Y1 - 2018/6
N2 - The recently discovered cyclohexanone monooxygenase from Thermocrispum municipale (TmCHMO) was employed in the preparation of different optically active sulfoxides. This novel Baeyer-Villiger monooxygenase (BVMO) shows a similar substrate specificity and selectivity when compared with the prototype CHMO from Acinetobacter calcoaceticus. Interestingly, TmCHMO is able to catalyse the asymmetric sulfoxidations at relatively high temperatures, substrate concentrations and in the presence of organic solvents while maintaining or even increasing its selectivity. This shows that this newly found biocatalyst is a promising catalyst for the synthesis of optically active sulfoxides.
AB - The recently discovered cyclohexanone monooxygenase from Thermocrispum municipale (TmCHMO) was employed in the preparation of different optically active sulfoxides. This novel Baeyer-Villiger monooxygenase (BVMO) shows a similar substrate specificity and selectivity when compared with the prototype CHMO from Acinetobacter calcoaceticus. Interestingly, TmCHMO is able to catalyse the asymmetric sulfoxidations at relatively high temperatures, substrate concentrations and in the presence of organic solvents while maintaining or even increasing its selectivity. This shows that this newly found biocatalyst is a promising catalyst for the synthesis of optically active sulfoxides.
KW - Baeyer-Villiger monooxygenase
KW - Biocatalysis
KW - Solvent engineering
KW - Sulfoxidations
KW - Thermostable enzymes
UR - https://www.scopus.com/pages/publications/85042451378
U2 - 10.1016/j.enzmictec.2018.02.006
DO - 10.1016/j.enzmictec.2018.02.006
M3 - Article
C2 - 29602383
AN - SCOPUS:85042451378
SN - 0141-0229
VL - 113
SP - 24
EP - 28
JO - Enzyme and Microbial Technology
JF - Enzyme and Microbial Technology
ER -